Skip to content

Clinical trials

Systemic Inflammatory Response Syndrome trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Systemic Inflammatory Response Syndrome Country / region: Germany Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20051
20061
20071
20082
20091
20121
20131
20141
20163
20171
20181
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Ulm4
InflaRx GmbH2
Vantive Health LLC2
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
Goethe University1
Hannover Medical School1
Ludwig-Maximilians - University of Munich1
Martin-Luther-Universität Halle-Wittenberg1
Mundipharma Research Limited1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Systemic Inflammatory Response Syndrome19
Sepsis10
Infections5
Inflammation5
Critical Illness4
Acute Kidney Injury3
Multiple Trauma3
Pathologic Processes3
Shock3
Candidemia2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.